Jon Russell

Summary

Affiliation: University of Texas Health Science Center
Country: USA

Publications

  1. pmc An internet survey of 2,596 people with fibromyalgia
    Robert M Bennett
    Oregon Health and Science University, Portland, OR, USA
    BMC Musculoskelet Disord 8:27. 2007
  2. pmc Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis
    Robert M Bennett
    Oregon Health and Science University, Portland, Oregon, USA
    BMC Musculoskelet Disord 11:134. 2010
  3. pmc Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome
    Dina Dadabhoy
    Northwest Rheumatology Specialists, Elk Grove Village, IL 60007, USA
    Arthritis Res Ther 10:211. 2008
  4. ncbi request reprint Reduction of morning stiffness and improvement in physical function in fibromyalgia syndrome patients treated sublingually with low doses of human interferon-alpha
    I J Russell
    Department of Medicine and The University Clinical Research Center, The University of Texas Health Science Center, San Antonio 78284 7868, USA
    J Interferon Cytokine Res 19:961-8. 1999
  5. doi request reprint Neurophysiopathogenesis of fibromyalgia syndrome: a unified hypothesis
    I Jon Russell
    Department of Medicine, Division of Clinical Immunology and Rheumatology, University Clinical Research Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229 3900, USA
    Rheum Dis Clin North Am 35:421-35. 2009
  6. doi request reprint Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial
    I Jon Russell
    The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229 3900, USA
    Arthritis Rheum 60:299-309. 2009
  7. doi request reprint Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study
    I Jon Russell
    Department of Medicine, University of Texas Health Science Center at San Antonio, TX, USA
    Pain 152:1007-17. 2011
  8. ncbi request reprint Lymphocyte markers and natural killer cell activity in fibromyalgia syndrome: effects of low-dose, sublingual use of human interferon-alpha
    I J Russell
    Department of Medicine, University Clinical Research Center, The University of Texas Health Science Center, San Antonio 78284 7868, USA
    J Interferon Cytokine Res 19:969-78. 1999
  9. ncbi request reprint The promise of substance P inhibitors in fibromyalgia
    I Jon Russell
    University of Texas Health Science Center at San Antonio, Mail Code 7868, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Rheum Dis Clin North Am 28:329-42. 2002
  10. doi request reprint The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome
    I Jon Russell
    University Clinical Research Center, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, MC7868, San Antonio, TX 78229, USA
    Sleep Med 10:604-10. 2009

Detail Information

Publications20

  1. pmc An internet survey of 2,596 people with fibromyalgia
    Robert M Bennett
    Oregon Health and Science University, Portland, OR, USA
    BMC Musculoskelet Disord 8:27. 2007
    ....
  2. pmc Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis
    Robert M Bennett
    Oregon Health and Science University, Portland, Oregon, USA
    BMC Musculoskelet Disord 11:134. 2010
    ..The purpose of this study was to determine whether some of the clinical features of fibromyalgia (FM) that patients would like to see improved aggregate into definable clusters...
  3. pmc Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome
    Dina Dadabhoy
    Northwest Rheumatology Specialists, Elk Grove Village, IL 60007, USA
    Arthritis Res Ther 10:211. 2008
    ..Concerted efforts to systematically evaluate additional objective measures in research trials will be vital for ongoing progress in outcome research and translation into clinical practice...
  4. ncbi request reprint Reduction of morning stiffness and improvement in physical function in fibromyalgia syndrome patients treated sublingually with low doses of human interferon-alpha
    I J Russell
    Department of Medicine and The University Clinical Research Center, The University of Texas Health Science Center, San Antonio 78284 7868, USA
    J Interferon Cytokine Res 19:961-8. 1999
    ..01). None of the other outcome means changed significantly and no adverse events were attributable to IFN-alpha therapy...
  5. doi request reprint Neurophysiopathogenesis of fibromyalgia syndrome: a unified hypothesis
    I Jon Russell
    Department of Medicine, Division of Clinical Immunology and Rheumatology, University Clinical Research Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229 3900, USA
    Rheum Dis Clin North Am 35:421-35. 2009
    ..A conceptual model at the molecular level is proposed to explain many of the observed features of FMS. The model can also explain anticipated responses to FDA approved pharmacologic therapies...
  6. doi request reprint Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial
    I Jon Russell
    The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229 3900, USA
    Arthritis Rheum 60:299-309. 2009
    ..To evaluate the safety and efficacy of sodium oxybate for management of the symptoms of fibromyalgia syndrome (FMS)...
  7. doi request reprint Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study
    I Jon Russell
    Department of Medicine, University of Texas Health Science Center at San Antonio, TX, USA
    Pain 152:1007-17. 2011
    ..These results expand the evidence from previous clinical trials suggesting that SXB is effective and safe in FM...
  8. ncbi request reprint Lymphocyte markers and natural killer cell activity in fibromyalgia syndrome: effects of low-dose, sublingual use of human interferon-alpha
    I J Russell
    Department of Medicine, University Clinical Research Center, The University of Texas Health Science Center, San Antonio 78284 7868, USA
    J Interferon Cytokine Res 19:969-78. 1999
    ..These data do not support an immunologically dysfunctional PBML phenotype among patients with FMS as has been observed in the chronic fatigue syndrome...
  9. ncbi request reprint The promise of substance P inhibitors in fibromyalgia
    I Jon Russell
    University of Texas Health Science Center at San Antonio, Mail Code 7868, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Rheum Dis Clin North Am 28:329-42. 2002
    ..However, there is still reason to predict valuable clinical uses for more potent NK1 receptor antagonists in a variety of medical conditions, including FMS...
  10. doi request reprint The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome
    I Jon Russell
    University Clinical Research Center, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, MC7868, San Antonio, TX 78229, USA
    Sleep Med 10:604-10. 2009
    ..Sleep disturbances are common in patients with fibromyalgia (FM). The objective of this analysis was to evaluate the effects of pregabalin on sleep in patients with FM...
  11. doi request reprint Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial
    I Jon Russell
    University of Texas Health Science Center, San Antonio, TX, USA
    Pain 136:432-44. 2008
    ..Study results demonstrated that duloxetine at doses of 60 mg/day and 120 mg/day appears to be safe and efficacious in patients with fibromyalgia...
  12. ncbi request reprint Fibromyalgia syndrome: approach to management
    I Jon Russell
    University Clinical Research Center, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
    CNS Spectr 13:27-33. 2008
    ..In addition, a logical basis is provided to help the clinician design strategic polypharmacy....
  13. ncbi request reprint Fibromyalgia syndrome: new developments in pathophysiology and management. Introduction
    I Jon Russell
    University Clinical Research Center, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
    CNS Spectr 13:4-5. 2008
  14. ncbi request reprint Fibromyalgia syndrome: presentation, diagnosis, differential diagnosis, and vulnerability
    I Jon Russell
    University Clinical Research Center, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
    CNS Spectr 13:6-11. 2008
    ..Existing data suggest that some individuals with FMS may have a dysregulated physiological stress response system that predates the onset of symptoms...
  15. ncbi request reprint Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial
    Leslie J Crofford
    University of Michigan, Ann Arbor, USA
    Arthritis Rheum 52:1264-73. 2005
    ..FMS affects an estimated 2% of the population, predominantly women. This trial was designed to evaluate the efficacy and safety of pregabalin, a novel alpha(2)-delta ligand, for treatment of symptoms associated with FMS...
  16. ncbi request reprint Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome
    Oludare B Taiwo
    University of Minnesota, Department of Veterinary and Biomedical Sciences, Rm 295, Animal Science Veterinary Medicine Building, 1988 Fitch Avenue, St Paul, MN 55113, USA
    Sleep Med 8:260-5. 2007
    ..Cerebrospinal fluid (CSF) hypocretin-1 (Hcrt-1) concentrations are low in patients with narcolepsy-cataplexy, a sleep disorder characterized by hypersomnolence and rapid eye movement (REM) sleep abnormalities...
  17. doi request reprint Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises
    Phillip J Mease
    Seattle Rheumatology Associates, Seattle, Washington 98104, USA
    Arthritis Rheum 59:952-60. 2008
    ....
  18. doi request reprint A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia
    Lesley M Arnold
    University of Cincinnati College of Medicine, Cincinnati, Ohio 45219, USA
    J Pain 9:792-805. 2008
    ..Compared with placebo, all 3 doses of pregabalin were associated with significant improvement in sleep. The most commonly reported pregabalin-related adverse events were dizziness and somnolence, which tended to be dose-related...
  19. ncbi request reprint Fibromyalgia syndrome
    Philip Mease
    Seattle Rhumatology Associates, Seattle, WA 98104, USA
    J Rheumatol 34:1415-25. 2007
    ..The OMERACT process has provided a framework for identification of key domains to be assessed and a path toward validation and standardization of outcome measures for clinical trials in FM...
  20. ncbi request reprint A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia
    Philip J Mease
    Seattle Rheumatology Associates, Seattle, Washington 98104, USA
    J Rheumatol 35:502-14. 2008
    ..To evaluate the efficacy and safety of pregabalin for symptomatic relief of pain associated with fibromyalgia (FM) and for management of FM...